The Scientific Advisory Board advises the Board of Directors of the Princess Máxima Center on setting up the research program, the infrastructure, and strategic partnerships for research. The Board consists (inter)national members who have been asked to join on the basis of their exceptional knowledge and expertise in (pediatric) oncology research.
The Scientific Advisory Board of the Princess Máxima Center consists of the following distinguished members:
Prof. Dr. Bill Evans-chair
Pharmacogenomics, St. Jude Children's Research Hospital, Memphis, TN, USA
Dr. Stefan Pfister
Pediatric Neurooncology, University of Heidelberg, Heidelberg, Germany
Prof. Dr. Kathy Pritchard-Jones
Pediatric kidney cancer, University College London Great Ormond Street Institute of Child Health, London, UK
Prof. Dr. Scott Armstrong
Epigenetics research and leukemia, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Prof. Dr. Melissa Hudson
Cancer Survivorship, St. Jude Children's Research Hospital, Memphis, TN, USA
Prof. Dr. Anne Kazak
Pediatric psychology, Center for Health Care Delivery Science, Nemours Children’s Health System, Wilmington, DE USA Department of Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA USA
Prof. Dr. Hidde Ploegh
Immuno-oncology, Boston Children’s Hospital, Program in Cellular and Molecular Medicine, Boston, MA, USA
Prof. Dr. René Medema
Cell cycle regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands